Recent advances in glucose-responsive insulin delivery systems: novel hydrogels and future applications

Over the past several decades, there have been major advancements in the field of glucose sensing and insulin delivery for the treatment of type I diabetes mellitus. The introduction of closed-loop insulin delivery systems that deliver insulin in response to specific levels of glucose in the blood has shifted significantly the research in this field. These systems consist of encapsulated glucose-sensitive components such as glucose oxidase or phenylboronic acid in hydrogels, microgels or nanoparticles. Since our previous evaluation of these systems in a contribution in 2004, new systems have been developed. Important improvements in key issues, such as consistent insulin delivery over an extended period of time have been addressed. In this contribution, we discuss recent advancements over the last 5 years and present persisting issues in these technologies that must be overcome in order for these systems to be applicable in patients.

Automated summary

There have been significant advancements in glucose sensing and insulin delivery for treating type I diabetes mellitus in the past few decades. The introduction of closed-loop insulin delivery systems has shifted the research focus in this field. In this contribution, recent advancements over the last 5 years are discussed, along with persisting issues in these technologies.